Completed NA INTERVENTIONAL 1-arm NCT00853710

Test Semiquantitative Prostate Specific Antigen (PSA)

Validation of a Semiquantitative Screening Assay for PSA

Sponsor: Institut Curie

Conditions Prostate Cancer Prostatic Diseases Prostatic Neoplasms

Interventions PSA assay

Updated 8 times since 2017 Last updated: Nov 19, 2025 Started: Mar 31, 2009 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Prostate Cancer and Prostatic Diseases and is currently completed. Institut Curie leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Dec 2025 — Present [monthly]

Completed NA
Sep 2025 — Dec 2025 [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Sep 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Sep 2017 [monthly]

Completed NA

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Curie

Data source: Institut Curie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint-Cloud, France